Since its inception, MiCardia Corporation has built an experienced technical and clinical team, while creating a comprehensive intellectual property portfolio. The Company’s first generation product, enCor™, was developed as a dynamically activated annuloplasty device to correct residual mitral regurgitation, intra-operatively, on a beating heart.

A second generation device, using the dynamic technology, received CE Mark in 2011. The enCorSQ™ is unique in its ability to affect recurrent mitral regurgitation days, weeks, months or years after the implant procedure, without an additional surgery.

Learn More About MiCardia

MICARDIA®, MICARDIA CORPORATION®, The M Logo®, ENCORSQ™, ENCORSQ MITRAL REPAIR SYSTEM™, DYNAPLASTY™ and DYNAPLASTY SYSTEM™ are trademarks of MiCardia Corporation. The ® symbol indicates that it is registered in the U.S. The ™ symbol indicates that the mark is not registered in the U.S.